Search
-
Device Agnostic: What Marketer’s Need to Know
Device agnostic is the new research reality. Today, over half of the global population use smartphones – a number predicted to rise to 70% in 2021. There is no doubt that allowing respondents to take surveys on smartphones represents a critical tipping point for our industry. We must adapt quickly to stay connected to consumers, but with that comes risk as we need to rethink questionnaire design to meet respondents’ expectations on mobile.
-
Behavioural Science
Behavioural Science at Ipsos is the use of psychology to help both public sector and brands meet their goals. The theories and methods from psychology work alongside MR techniques to understand and predict behaviour, generating total customer understanding.
-
Global Views on Immigration and the Refugee Crisis
Three in four (75%) in 25 countries around the world believe that immigration has increased in their country over the last five years, according to new data from the Ipsos Global @dvisor survey.
-
Commercial Drone Adoption in Agribusiness - Disruption & Opportunitiy
Civilian use of 'unmanned aerial vehicles (UAVs)', more commonly known as 'Drones', has gained traction with both consumer and commercial users in recent years.
-
Unlocking the Opportunities for Crop Science Products in CLMV
Cambodia, Lao PDR, Myanmar, and Vietnam, collectively known as CLMV, account for a third of ASEAN geographical area and experience continuous growth in both GDP and population.
-
Using Social Intelligence for a Sharper Vision of Your Brand and Category
Marketers need to understand their category’s dynamics to optimally position themselves and compete effectively. To do this, they must get the consumer’s perspective – because consumers, not industries, are defining today’s markets.
-
Device Agnostic Surveys a Necessary Evolution 2017
What are device-agnostic surveys? “Device-agnostic” implies that respondents can take in-browser surveys on any device they choose.
-
Conquering Complexity: The Coming Revolution in Oncology Biomarker Testing
Despite the advent of targeted therapies and the associated rise in the use of companion and complementary diagnostics, we are only just emerging from the initial exploratory stages of oncology biomarker testing. As will be argued in this paper, we are on the cusp of a much more radical revolution, and the molecular diagnostics landscape is set to change dramatically in the coming decades. It is crucial that any company entering this space prepare for this imminent upheaval and plan their launch strategy accordingly.
-
The Role of Surveys in the Age of Behavioural Science
A challenge that market research is increasingly facing is why, in a world where behavioural science apparently suggests that are limits to what consumers tell us, do we continue to ask questions?